GARP:BATS-iShares MSCI USA Quality GARP ETF (USD)

ETF | Others |

Last Closing

USD 51.07

Change

+1.66 (+3.36)%

Market Cap

USD 0.32B

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-24 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
FBTC Fidelity Wise Origin Bitcoin T..

+0.10 (+0.12%)

USD 16.57B
INDA iShares MSCI India ETF

+0.56 (+1.05%)

USD 8.63B
PAVE Global X U.S. Infrastructure D..

+1.09 (+2.95%)

USD 7.86B
BUFR First Trust Cboe Vest Fund of ..

+0.42 (+1.46%)

USD 6.45B
BOXX Alpha Architect 1-3 Month Box ..

+0.01 (+0.01%)

USD 5.75B
BBUS JPMorgan BetaBuilders U.S. Equ..

+2.06 (+2.13%)

USD 4.20B
ARKB ARK 21Shares Bitcoin ETF

+0.13 (+0.14%)

USD 4.01B
KNG FT Cboe Vest S&P 500® Dividen..

+0.27 (+0.56%)

USD 3.66B
GSUS Goldman Sachs MarketBeta US Eq..

+1.55 (+2.10%)

USD 2.47B
IFRA iShares U.S. Infrastructure ET..

+0.74 (+1.66%)

USD 2.19B

ETFs Containing GARP

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -9.21% 10% F 10% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -9.21% 10% F 9% A-
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.32B 86% B+ 78% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike